Contingency planning and risk mitigation strategies for a schizophrenia relapse prevention trial during the COVID-19 pandemic

por Davis, G., Eshet, R., Kane, J.M., Mangold, S., Tohami, O., Taylor, S., Benedek, M., Harary, E.
Publicado 2022

Detecting relapse in youth with psychotic disorders utilizing patient-generated and patient-contributed digital data from Facebook

por Birnbaum, M. L., Ernala, S. K., Rizvi, A. F., Arenare, E., R. Van Meter, A., De Choudhury, M., Kane, J. M.
Publicado 2019

The heterogeneity of antipsychotic response in the treatment of schizophrenia

por Case, M., Stauffer, V. L., Ascher-Svanum, H., Conley, R., Kapur, S., Kane, J. M., Kollack-Walker, S., Jacob, J., Kinon, B. J.
Publicado 2011

Pharmacovigilance analysis of the Vigibase on antidepressants-related withdrawal syndrome in adults and adolescents

por Gastaldon, C., Schoretsanitis, G., Arzenton, E., Raschi, E., Papola, D., Ostuzzi, G., Moretti, U., Seifritz, E., Kane, J. M., Trifirò, G., Barbui, C.
Publicado 2023

Thromboembolic Events Associated with Thalidomide and Multimodality Therapy for Soft Tissue Sarcomas: Results of RTOG 0330

por Kane, J. M., Harris, J., Kraybill, W. G., Harmon, D. C., Ettinger, D. S., Lucas, D. R., DeLaney, T. F., Wang, D., Curran, W. J., Eisenberg, B. L.
Publicado 2012